Bangkok Lab And Cosmetic

BLC

THB407010008

Pharmaceuticals

End-of-day quote Thailand S.E. Other stock markets 06:00:00 2024-07-16 pm EDT			5-day change	1st Jan Change
4.8 ^THB	-2.44%		-5.88%	+4.35%

Jun. 21	Certain Shares of Bangkok Lab And Cosmetic Public Company Limited are subject to a Lock-Up Agreement Ending on 21-JUN-2024.	CI
Jun. 13	Bangkok Lab & Cosmetic Public Company Limited Announces Establishment of A Subsidiary	CI

Bangkok Lab and Cosmetic Public Company Limited Announces Changing of Chief Accountant

February 01, 2024 at 01:29 am EST

Bangkok Lab And Cosmetic Public Company Limited appointed Miss Phiraya Chanpatya as Chief Accountant in place of Miss Supaporn Kumyoo. Effective Date of Appointment 01 Feb. 2024.

Latest news about Bangkok Lab And Cosmetic

Certain Shares of Bangkok Lab And Cosmetic Public Company Limited are subject to a Lock-Up Agreement Ending on 21-JUN-2024.	Jun. 20	CI
Bangkok Lab & Cosmetic Public Company Limited Announces Establishment of A Subsidiary	Jun. 13	CI
Bangkok Lab And Cosmetic Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 13	CI
Bangkok Lab And Cosmetic Public Company Limited Approves Final Dividend for the Year 2023, Payable on April 30, 2024	Apr. 01	CI
Bangkok Lab and Cosmetic Public Company Limited Proposes the Dividend Payment for the Year 2023, Payable on April 30, 2024	Feb. 28	CI
Bangkok Lab And Cosmetic Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 28	CI
Bangkok Lab and Cosmetic Public Company Limited Announces Changing of Chief Accountant	Feb. 01	CI
Certain Shares of Bangkok Lab And Cosmetic Public Company Limited are subject to a Lock-Up Agreement Ending on 21-DEC-2023.	Dec. 20	CI
Bangkok Lab And Cosmetic Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
Bangkok Lab and Cosmetic Public Company Limited Declares Cash Dividend Payment for the Operating Period from 01 January 2023 to 30 June 2023, Payable on 14 September 2023	23-08-14	CI
Bangkok Lab And Cosmetic Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
Bangkok Lab And Cosmetic Public Company Limited has completed an IPO in the amount of THB 1.575 billion.	23-06-20	CI
Bangkok Lab And Cosmetic Public Company Limited has filed an IPO.	22-12-25	CI

Chart Bangkok Lab And Cosmetic

Duration

Period

More charts

Bangkok Lab and Cosmetic Public Company Limited is a Thailand-based producer and researcher of health products. The principal activities of the Company and subsidiaries are engaged in the manufacturing and distributing of pharmaceuticals and medicinal chemical products for humans and animals. It operates through pharmaceuticals and medicinal chemical products segment. Its products include ZENZERA 200 SUSPENSION, ZENZERA, SYNOVAR UC40, RADIARA, PROCEMINE, FANGO-B, EMBLICOF COUGH MIXTURE, CLINIGEL STERILE, RAQUA FIBROTA, RAQUA COLLAGEN, SYNOVAR UC, SYNOVAR POWDER, NACOXIB, LUTI-BERRY MIXED, ZIGA GEL (orange), ZERTINE SYRUP, VIZO Cream, SPORAXYL CREAM, NORAPHEN, MURHINOL-250 SYRUP, NORFLOXYL 400, NOCID, MURHINOL-250 SYRUP, MUCOBROX, GYNOSTEN CREAM, and GYNOSTEN 500, AROTIKA COOL GEL, ALLERAX-FC, AROTIKA RUB LOTION (SPRAY), Calza c Dietary Supplement, Calza PLUS POWDER Dietary, Calza-750 TAB FC, and others. Its subsidiaries include Bangkok Drug Co., Ltd., and Pharma Alliance Co., Ltd.

Sector

Pharmaceuticals

Calendar

2024-08-12 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
BANGKOK LAB AND COSMETIC	+4.35%	81.89M
ELI LILLY AND COMPANY	+57.04%	848B
NOVO NORDISK A/S	+31.64%	627B
JOHNSON & JOHNSON	-0.03%	363B
MERCK & CO., INC.	+15.46%	318B
ABBVIE INC.	+12.65%	299B
ASTRAZENECA PLC	+15.51%	243B
NOVARTIS AG	+16.72%	225B
AMGEN INC.	+16.30%	179B
PFIZER, INC.	+4.09%	167B